Impact of Loper Bright on the Regulation of Biotechnology Webinar

The Linde Center for Science, Society, and Policy (LCSSP) at Caltech hosted a webinar on October 16, 2024 from 10 am to 12 pm PDT on the potential impacts of the recent Supreme Court Loper Bright (post-Chevron) decision on future regulation of biotechnology products. The panelists provided their perspectives and answered participant questions to explore how the Supreme Court's decision to overturn the Chevron deference doctrine may (or may not) affect the Coordinated Framework for the Regulation of Biotechnology. Here is the list of panelists:
Sarah Carter: Principal at Science Policy Consulting LLC. For ~15 years, focused on policy issues related to tools and capabilities for engineering biology, including biosecurity and the potential for misuse, U.S. government oversight and regulation, industry practices, and responsible innovation.
Barbara Evans: Professor of Law and Stephen C. O'Connell Chair at the University of Florida Levin College of Law. Her work focuses on data privacy and the regulation of AI/ML medical software, genomic technologies, and diagnostic testing. She was a member of the NASEM panel on future products of biotechnology and the coordinated framework.
Keith Matthews: Former Director of the Biopesticides and Pollution Prevention Division (BPPD) in the U.S. EPA's Office of Pesticide Programs (OPP), now in private practice at Matthews Law LLC, where he focuses on regulatory counseling related to agricultural biotechnology, chemicals, and bioengineered foods.
Chris Wozniak: Retired from Environmental Protection Agency in November 2021 after 20 plus years and formed an LLC consulting business the following spring. At EPA, worked primarily with the regulation of biopesticides, including microbial pest control agents, genetically engineered plants with pesticidal properties like disease or insect resistance, and genetically engineered mosquitoes intended to reduce populations of specific vectors.